[
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug",
    "summary": "We recently compiled a list of the 12 Most Undervalued Dow Stocks to Buy According to Analysts. Merck & Co., Inc. is one of them. Merck & Co., Inc. (NYSE:MRK) tops our list for being one of the most undervalued stocks. It is a global healthcare leader in pharmaceuticals, vaccines, biologics, and animal health products. A […]",
    "url": "https://finnhub.io/api/news?id=f9e79fc256e8ee308e7dae0977dd2ff7d36e740d6d57d209c5ac5ae7a670ab80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759099368,
      "headline": "Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug",
      "id": 136913670,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Most Undervalued Dow Stocks to Buy According to Analysts. Merck & Co., Inc. is one of them. Merck & Co., Inc. (NYSE:MRK) tops our list for being one of the most undervalued stocks. It is a global healthcare leader in pharmaceuticals, vaccines, biologics, and animal health products. A […]",
      "url": "https://finnhub.io/api/news?id=f9e79fc256e8ee308e7dae0977dd2ff7d36e740d6d57d209c5ac5ae7a670ab80"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's Bold GLP‑1 Comeback, Dividend Safe For Now",
    "summary": "Pfizer acquires Metsera to enter the booming obesity drug market with next-gen GLP-1 therapies. Find out why PFE stock is a hold.",
    "url": "https://finnhub.io/api/news?id=eb1a03a9afdaa0d5ecccf5745dcdfb5f6c13a3da36e40decc43d09225954d1f8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759039378,
      "headline": "Pfizer's Bold GLP‑1 Comeback, Dividend Safe For Now",
      "id": 136906174,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Pfizer acquires Metsera to enter the booming obesity drug market with next-gen GLP-1 therapies. Find out why PFE stock is a hold.",
      "url": "https://finnhub.io/api/news?id=eb1a03a9afdaa0d5ecccf5745dcdfb5f6c13a3da36e40decc43d09225954d1f8"
    }
  }
]